No abstract

No abstract

Implant stability plays a critical role for osseointegration, without osseointegration long term success cannot be achieved, primary stability occurs from mechanical attachment with the cortical bone. It is the gold standard for success of implants. This is a descriptive clinical study carried out in saveetha dental college and hospital, Poonamallee, Chennai. All the patients who underwent single or two-unit implant surgery were selected. The study setting was done from university predominantly south Indian populations and data with regard to primary stability at placement, level of the implant with bone, crestal bone loss at stage 2 recovery were retrieved from the digital case sheets. Data were entered using SPSS software, and Chi-square test was used for inferential analysis, with a P-value < 0.05 was said to be statistically significant. The results obtained indicate more implants are placed with primary stability in 30-40 Ncm(49.8%). More frequently placed crestal relation is equi crestal region (84.4%) and crestal bone loss was less than 1-2mm is seen(87.3%) at stage 2 recovery. The results were subjected to statistical chi-square test, and it is observed that primary stability at 30-40 Ncm or greater did not have any significant association with crestal bone loss. An equi crestal placement of the implant was preferred irrespective of implant type.

First identified by the Egyptians in 2640 BC, podagra (acute gout occurring in the first metatarsophalangeal joint) was later recognized by Hippocrates in the fifth century BC, who referred to it as 'the unwalkable disease'. The term is derived from the Latin word gutta (or 'drop'), and referred to the prevailing medieval belief that an excess of one of the four 'humors' - which in equilibrium were thought to maintain health - would, under certain circumstances, 'drop' or flow into a joint, causing pain and inflammation. Throughout history, gout has been associated with rich foods and excessive alcohol consumption. Because it is clearly associated with a lifestyle that,atleast in the past, could only be afforded by the affluent, gout has been referred to as the 'disease of kings'. Although there is evidence that colchicine, an alkaloid derived from the autumn crocus (Colchicum autumnale), was used as a powerful purgative in ancient Greece more than 2000 years ago, its first use as a selective and specific treatment for gout is attributed to the Byzantine Christian physician Alexander of Tralles in the sixth century AD.